A placebo-controlled trial of a pertussis-toxoid vaccine.
about
Acellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenAcellular vaccines for preventing whooping cough in childrenMolecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology toolsRoads to the development of improved pertussis vaccines paved by immunologyIdentification of peptides that mimic the pertussis toxin binding site on bovine fetuin.Acellular pertussis vaccine efficacy: An updated systematic review and meta -analysis.Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infections.A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolutionDiagnosis and management of pertussis.Analysis of Bordetella pertussis populations in European countries with different vaccination policiesProtective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge modelSerum immunoglobulin G antibody responses to Bordetella pertussis lipooligosaccharide and B. parapertussis lipopolysaccharide in children with pertussis and parapertussisAcellular pertussis vaccines and the role of pertactin and fimbriae.Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children.Update on pertussis in children.Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model.Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany.Pertussis vaccine: a critique.Expression of a C terminally truncated form of pertussis toxin S1 subunit effectively induces protection against pertussis toxin following DNA-based immunization.Pertussis: persistent pathogen, imperfect vaccines.Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens.Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908Toxicity and potency evaluation of pertussis vaccines.Acellular pertussis vaccines for use among infants and young children.Acellular pertussis vaccines have arrivedWhat is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?Antibody-mediated neutralization of pertussis toxin-induced mitogenicity of human peripheral blood mononuclear cells.Laboratory diagnosis of pertussis: state of the art in 1997.Serologic evidence of pertussis infection in vaccinated Iranian children.Substantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacyProtective Effect of Contemporary Pertussis Vaccines: A Systematic Review and Meta-analysis.Unexpected loss of contact allergy to aluminium induced by vaccine.Licensed pertussis vaccines in the United States. History and current state.Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination.Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States.Toward a new vaccine for pertussis
P2860
Q24193554-64D31C83-D9BC-4D0E-984C-4B20B75B4EE2Q24201103-55BA3761-1B91-4B63-A02C-F7D0721EDA48Q24234899-CFACD52D-FF4D-4436-9D51-1D08FA78E27EQ24243261-75D6E969-064D-41F8-86D0-43DEF035BE47Q24522458-F012A4E8-1432-454C-8C1E-C54D8C9F46CEQ24602050-15235AF9-19C2-4D0F-A760-BC7D93BA387AQ26782939-4273220E-A8EF-4E09-9F0F-53D9C867CFEFQ30451682-C37A7463-8544-4783-BA63-4A3F24AD09C5Q33642326-7CA0493C-E55C-47BF-928E-D3FEC9A0ACDEQ33659015-FEFC59BE-BCA6-406D-A3AA-BE64DFC11AD4Q33750257-C03A1432-BB48-44CC-960B-9DE20A510B5EQ33750402-C0A079AC-C3CE-488E-8CE2-DF7BDFF3B9A7Q33833442-1FD3FDE1-9523-4160-A07E-B25334A63160Q33856228-09C09045-DB9C-4FED-9724-445B2D669229Q33866775-865DB1FE-9468-4819-BE7F-320DB8189887Q33999534-75EBC35E-99C6-4928-B283-0338C4647390Q34002283-3B0D71AF-4744-4CA4-B097-C320BF825E2BQ34013394-1236E220-0E70-406B-A967-F9B60023AF43Q34095301-01C17626-1496-4728-89EA-6DD771F16D8FQ34129001-55F03523-1A26-4068-A768-C054D0040834Q34135825-A0F254F9-A812-4B99-9096-C9FC5A3A8C13Q34657980-7A230806-C9C9-411E-A000-BCF868DC2F4EQ34758995-98E73720-1532-4ECA-9DC6-5AC50AC4C2E0Q35193561-9E5AC1DB-B0FC-430A-8E13-281F7DBFB06FQ35228085-0FAD3F04-E587-4274-A5EC-757E7EE9524BQ35524357-54D189EE-70BE-44B1-9AE4-3B5364296229Q35648263-BF8EC227-50A8-4742-A47E-430A6A461D0EQ35753402-690AA093-A0FB-451C-866E-F197D718AE1AQ35891547-71F162EC-8790-41D8-89E1-4F67654E5A13Q35999835-E0FC76BB-09C5-4B96-951D-4A5BA198759BQ36228236-817D32E5-BDCB-4C88-A1C0-7BC705DCD5E6Q36546648-3734D6E9-B01C-4C18-8D68-12559B4F6A15Q36589704-BECCDC28-45D1-4557-8A26-65A1862B8844Q36688886-FB69054F-6D4C-4EF9-9FE7-81C1BFB9B0BEQ36783198-F9B59131-BDB0-44C4-99F4-FD73A3447387Q37073012-AA8C5711-6D45-4B1F-85C6-61DFE5A0A816Q37154787-7F9C2E7B-46A6-4BED-9C89-E54B9DC237D9Q37469628-24E8715A-F08B-49AB-A2F3-C2A334F2E7EBQ37595138-D80718DB-B429-4CAA-B5AB-CA0788EADB8CQ37628007-D80E4FA3-0DF3-460F-9F22-754A6057C4F3
P2860
A placebo-controlled trial of a pertussis-toxoid vaccine.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
A placebo-controlled trial of a pertussis-toxoid vaccine.
@en
type
label
A placebo-controlled trial of a pertussis-toxoid vaccine.
@en
prefLabel
A placebo-controlled trial of a pertussis-toxoid vaccine.
@en
P2093
P1476
A placebo-controlled trial of a pertussis-toxoid vaccine.
@en
P2093
Blackwelder W
Lagergård T
Robbins JB
Taranger J
Trollfors B
Zackrisson G
P304
P356
10.1056/NEJM199510193331604
P407
P577
1995-10-01T00:00:00Z